Literature DB >> 18281468

Stroma-initiated hedgehog signaling takes center stage in B-cell lymphoma.

Ralph K Lindemann1.   

Abstract

Hedgehog-mediated signaling has been shown to promote growth and dissemination of solid cancers, most prominently basal cell carcinomas and medulloblastoma. Recent findings indicate that hedgehog signals are also important for tumor growth in hematologic malignancies. Hedgehog ligands secreted by stromal cells could elicit Patched/Smoothened-mediated antiapoptotic signaling in mouse B-cell lymphomas. Inhibition of hedgehog signaling induced apoptosis in lymphoma cells and prolonged survival of lymphoma-bearing mice. Depletion of tumor cells proceeded in the absence of p53 via the mitochondrial apoptotic pathway. These and other recently published data on hedgehog inhibition in cancer cells and their implications will be discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18281468     DOI: 10.1158/0008-5472.CAN-07-5500

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

Review 1.  Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.

Authors:  Wan Zhang; Peng Huang
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

Review 2.  Mesenchymal niches of bone marrow in cancer.

Authors:  Ander Abarrategi; Luis Marińas-Pardo; Isabel Mirones; Esther Rincón; Javier García-Castro
Journal:  Clin Transl Oncol       Date:  2011-09       Impact factor: 3.405

3.  A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance.

Authors:  Zhiqiang Liu; Jingda Xu; Jin He; Yuhuan Zheng; Haiyan Li; Yong Lu; Jianfei Qian; Pei Lin; Donna M Weber; Jing Yang; Qing Yi
Journal:  Blood       Date:  2014-07-21       Impact factor: 22.113

Review 4.  Novel disease targets and management approaches for diffuse large B-cell lymphoma.

Authors:  Wyndham H Wilson; Francisco J Hernandez-Ilizaliturri; Kieron Dunleavy; Richard F Little; Owen A O'Connor
Journal:  Leuk Lymphoma       Date:  2010-08

5.  Mice deficient in MIM expression are predisposed to lymphomagenesis.

Authors:  D Yu; X H Zhan; X F Zhao; M S Williams; G B Carey; E Smith; D Scott; J Zhu; Y Guo; S Cherukuri; C I Civin; X Zhan
Journal:  Oncogene       Date:  2011-11-14       Impact factor: 9.867

Review 6.  Implications of hedgehog signaling antagonists for cancer therapy.

Authors:  Jingwu Xie
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

Review 7.  The utility of hedgehog signaling pathway inhibition for cancer.

Authors:  Solmaz Sahebjam; Lillian L Siu; Albiruni A Razak
Journal:  Oncologist       Date:  2012-07-31

Review 8.  Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer.

Authors:  Monique T Barakat; Eric W Humke; Matthew P Scott
Journal:  Trends Mol Med       Date:  2010-06-16       Impact factor: 11.951

9.  Smoothened as a new therapeutic target for human osteosarcoma.

Authors:  Masataka Hirotsu; Takao Setoguchi; Hiromi Sasaki; Yukihiro Matsunoshita; Hui Gao; Hiroko Nagao; Osamu Kunigou; Setsuro Komiya
Journal:  Mol Cancer       Date:  2010-01-12       Impact factor: 27.401

Review 10.  Hedgehog signaling pathway in ovarian cancer.

Authors:  Joanna Szkandera; Tobias Kiesslich; Johannes Haybaeck; Armin Gerger; Martin Pichler
Journal:  Int J Mol Sci       Date:  2013-01-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.